230 related articles for article (PubMed ID: 21214223)
1. Novel glycan biomarkers for the detection of lung cancer.
Arnold JN; Saldova R; Galligan MC; Murphy TB; Mimura-Kimura Y; Telford JE; Godwin AK; Rudd PM
J Proteome Res; 2011 Apr; 10(4):1755-64. PubMed ID: 21214223
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
Fujimura T; Shinohara Y; Tissot B; Pang PC; Kurogochi M; Saito S; Arai Y; Sadilek M; Murayama K; Dell A; Nishimura S; Hakomori SI
Int J Cancer; 2008 Jan; 122(1):39-49. PubMed ID: 17803183
[TBL] [Abstract][Full Text] [Related]
3. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers.
Nakano M; Nakagawa T; Ito T; Kitada T; Hijioka T; Kasahara A; Tajiri M; Wada Y; Taniguchi N; Miyoshi E
Int J Cancer; 2008 May; 122(10):2301-9. PubMed ID: 18214858
[TBL] [Abstract][Full Text] [Related]
4. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
[TBL] [Abstract][Full Text] [Related]
5. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
6. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.
Tsai HY; Boonyapranai K; Sriyam S; Yu CJ; Wu SW; Khoo KH; Phutrakul S; Chen ST
Proteomics; 2011 Jun; 11(11):2162-70. PubMed ID: 21538882
[TBL] [Abstract][Full Text] [Related]
7. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
8. Greedy feature selection for glycan chromatography data with the generalized Dirichlet distribution.
Galligan MC; Saldova R; Campbell MP; Rudd PM; Murphy TB
BMC Bioinformatics; 2013 May; 14():155. PubMed ID: 23651459
[TBL] [Abstract][Full Text] [Related]
9. Discovery of sialyl Lewis A and Lewis X modified protein cancer biomarkers using high density antibody arrays.
Rho JH; Mead JR; Wright WS; Brenner DE; Stave JW; Gildersleeve JC; Lampe PD
J Proteomics; 2014 Jan; 96():291-9. PubMed ID: 24185138
[TBL] [Abstract][Full Text] [Related]
10. Sialylated N-glycans in adult rat brain tissue--a widespread distribution of disialylated antennae in complex and hybrid structures.
Zamze S; Harvey DJ; Chen YJ; Guile GR; Dwek RA; Wing DR
Eur J Biochem; 1998 Nov; 258(1):243-70. PubMed ID: 9851715
[TBL] [Abstract][Full Text] [Related]
11. N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.
Balog CI; Stavenhagen K; Fung WL; Koeleman CA; McDonnell LA; Verhoeven A; Mesker WE; Tollenaar RA; Deelder AM; Wuhrer M
Mol Cell Proteomics; 2012 Sep; 11(9):571-85. PubMed ID: 22573871
[TBL] [Abstract][Full Text] [Related]
12. Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.
Biskup K; Braicu EI; Sehouli J; Fotopoulou C; Tauber R; Berger M; Blanchard V
J Proteome Res; 2013 Sep; 12(9):4056-63. PubMed ID: 23889230
[TBL] [Abstract][Full Text] [Related]
13. Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC/MS and LC/MS/MS.
Lee SH; Jeong S; Lee J; Yeo IS; Oh MJ; Kim U; Kim S; Kim SH; Park SY; Kim JH; Park SH; Kim JH; An HJ
Mol Biosyst; 2016 Nov; 12(12):3611-3621. PubMed ID: 27722599
[TBL] [Abstract][Full Text] [Related]
14. Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung diseases by capillary electrophoresis.
Váradi C; Mittermayr S; Szekrényes Á; Kádas J; Takacs L; Kurucz I; Guttman A
Electrophoresis; 2013 Aug; 34(16):2287-94. PubMed ID: 23580236
[TBL] [Abstract][Full Text] [Related]
15. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma.
Comunale MA; Wang M; Hafner J; Krakover J; Rodemich L; Kopenhaver B; Long RE; Junaidi O; Bisceglie AM; Block TM; Mehta AS
J Proteome Res; 2009 Feb; 8(2):595-602. PubMed ID: 19099421
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the human seminal plasma glycome reveals the presence of immunomodulatory carbohydrate functional groups.
Pang PC; Tissot B; Drobnis EZ; Morris HR; Dell A; Clark GF
J Proteome Res; 2009 Nov; 8(11):4906-15. PubMed ID: 19606896
[TBL] [Abstract][Full Text] [Related]
17. Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation.
Bones J; Mittermayr S; O'Donoghue N; Guttman A; Rudd PM
Anal Chem; 2010 Dec; 82(24):10208-15. PubMed ID: 21073175
[TBL] [Abstract][Full Text] [Related]
18. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
19. Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay.
Wu J; Zhu J; Yin H; Buckanovich RJ; Lubman DM
J Proteome Res; 2014 Apr; 13(4):2197-204. PubMed ID: 24575722
[TBL] [Abstract][Full Text] [Related]
20. HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals.
Melmer M; Stangler T; Schiefermeier M; Brunner W; Toll H; Rupprechter A; Lindner W; Premstaller A
Anal Bioanal Chem; 2010 Sep; 398(2):905-14. PubMed ID: 20640408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]